대구한의대학교 향산도서관

상세정보

부가기능

Translating the Anti-Tumor/Anti-Cachectic Activity of AR-42, a Novel HDAC Inhibitor, into Pancreatic Cancer Therapy

상세 프로파일

상세정보
자료유형학위논문
서명/저자사항Translating the Anti-Tumor/Anti-Cachectic Activity of AR-42, a Novel HDAC Inhibitor, into Pancreatic Cancer Therapy.
개인저자Henderson, Sally Erin.
단체저자명The Ohio State University. Comparative and Veterinary Medicine.
발행사항[S.l.]: The Ohio State University., 2017.
발행사항Ann Arbor: ProQuest Dissertations & Theses, 2017.
형태사항153 p.
기본자료 저록Dissertations Abstracts International 81-05B.
Dissertation Abstract International
ISBN9781687947734
학위논문주기Thesis (Ph.D.)--The Ohio State University, 2017.
일반주기 Source: Dissertations Abstracts International, Volume: 81-05, Section: B.
Advisor: Chen, Ching-Shih.
이용제한사항This item must not be sold to any third party vendors.
요약Pancreatic cancer is the 3rd leading cause of cancer death in the United States and has a 5-year survival of less than 9% for all stages. Furthermore, cachexia, defined as severe weight loss due to depletion of muscle mass that is not reversible with conventional nutritional support, is seen in 85% of pancreatic cancer patients and contributes significantly to morbidity and mortality. Therefore, there is an urgent need to develop novel therapeutics that target tumor growth and muscle wasting in order to improve clinical outcomes. The first part of this study was aimed at evaluating the efficacy of AR-42, a novel histone deacetylase (HDAC) inhibitor developed in our laboratory, in suppressing tumor growth in mouse models of pancreatic cancer. The in vitro anti-proliferative activity of AR-42 was evaluated in six human pancreatic cancer cell lines. An AsPC-1 subcutaneous xenograft and transgenic KPfl/flC (LSL-KrasG12D
일반주제명Pharmacology.
Cellular biology.
Molecular biology.
언어영어
바로가기URL : 이 자료의 원문은 한국교육학술정보원에서 제공합니다.

서평(리뷰)

  • 서평(리뷰)

태그

  • 태그

나의 태그

나의 태그 (0)

모든 이용자 태그

모든 이용자 태그 (0) 태그 목록형 보기 태그 구름형 보기
 
로그인폼